Cam Gallagher

Cam Gallagher is a seasoned biopharmaceutical executive with extensive experience in founding and leading companies within the life sciences sector. As Co-Founder, President, and Board Member of Zentalis Pharmaceuticals, Gallagher has played a key role in developing small molecule therapeutics for cancer. Additional leadership roles include General Partner at Velosity Capital, a venture capital firm investing in innovative life sciences technologies, and Chairman of the Board of Directors at Ocuphire Pharma, which focuses on ophthalmic therapies. Gallagher's previous experience includes founding contributions at SelectION, Inc. and Ray Therapeutics, Inc., along with significant roles at companies such as VelosBio and Zavante Therapeutics. Gallagher holds an M.B.A. in Marketing and Finance from the University of San Diego and a Bachelor's degree in Business Administration from Ohio University.